April 6, 2024 The first trial of a novel strategy for removing cholesterol from patients arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiologys Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.
C. Michael Gibson, MD
We did not see a statistically significant reduction in the primary endpoint of risk for death, a heart attack or a stroke at 90 days, or a reduction in risk for stroke at any time, said C. Michael Gibson, MD, a professor of medicine at Harvard Medical School and the studys lead author. However, in an exploratory analysis of outcomes, treated patients had fewer heart attacks and heart-attack deaths than patients in the control group at six months, he said.
Although we missed our primary endpoint, our data support the hypothesis that HDL cholesterol plays a role in reducing subsequent coronary plaque disruption events like heart attack via enhanced cholesterol efflux attacks, Gibson said.
People who have had a heart attack are at high risk for another one, especially during the next 90 days, Gibson said. This study was the first in which patients received an infusion of ApoA-I, a component of HDL (good) cholesterol, shortly after a heart attack, with the aim of stabilizing coronary plaque and reducing adverse cardiovascular events. The investigational drug CSL112 used in the study is a form of ApoA-I thats extracted from human plasma, the liquid component of blood.
High levels of LDL cholesterol create a build-up of plaque in the arteries that carry blood to the heart, increasing risk for an arterial blockage that causes a heart attack. HDL cholesterol removes cholesterol from the arteries and carries it to the liver, which then excretes it. ApoA-I, the main component of HDL cholesterol, helps initiate the process of removing cholesterol from the body. A previous study showed that a single infusion of CSL112 reduced the amount of LDL cholesterol in arterial plaque by as much as 50%.
Other studies have shown that high levels of HDL cholesterol are associated with reduced heart attack risk. Recent research, however, suggests that the level of HDL cholesterol number may be less important for reducing heart attack risk than how well it performs at removing cholesterol, Gibson said.
We know that in the setting of a heart attack, when the HDL cholesterol is good at getting a lot of cholesterol out of the arteries, that results in better outcomes for patients, he said.
Gibson and his colleagues hypothesized that infusions of CSL112 given shortly after a heart attack mightby boosting the bodys ability to dispose of cholesterolreduce patients risk for a repeat heart attack during the next crucial 90 days. The international AEGIS-II trial, conducted in 49 countries, was designed to test this hypothesis.
The study enrolled 18,219 patients (median age 65.5 years, 74% men and 84.5% White) who had been hospitalized for a heart attack and had multiple blockages in arteries carrying blood to the heart that elevated their risk for another heart attack. They also had other risk factors, including having had a previous heart attack, receiving drug treatment for diabetes or being 65 or older. Patients were randomly assigned to receive infusions of either CSL112 or a placebo for four weeks, with the first infusion given within five days of hospitalization.
The studys primary endpoint was the time to the first occurrence of a major adverse cardiovascular event (MACE; i.e., heart attack, stroke or death due to heart disease or a stroke) at 90 days. Secondary endpoints included the time to the first occurrence of a MACE within six months and one year and of each specific event within 90 days, six months and one year.
At 90 days, patients treated with CSL112 had a 4.8% reduction in risk for death, heart attack or stroke compared with 5.2% for those treated with a placebo, a difference that was not statistically significant. In an exploratory analysis, however, patients treated with CSL112 were 14% less likely to have or die from a heart attack at 180 days. In addition, patients treated with CSL112 were 32% less likely to have a heart attack caused by a blood clot in a stent (a tiny mesh tube inserted into an artery to prevent it from becoming blocked) at 90 days and 29% less likely at 180 days.
Another potentially important finding, Gibson said, is that patients whose LDL cholesterol level was 100 mg/dL or higher at study entry experienced a 30% decrease in the primary endpoint, a statistically significant finding, whereas patients whose LDL cholesterol at study entry was less than 100 mg/dL saw no decrease in the primary endpoint.
Baseline LDL modulated the treatment effect, Gibson said.
Overall, our findings are consistent with ApoA-I having a role in stabilizing heart blockages and reducing the risk of a blockage that ruptures and causing a heart attack further out than 90 days, Gibson said. Its plausible that by giving ApoA-1 to clear the cholesterol out of the body and then treating the patient with cholesterol-lowering medications to keep LDL cholesterol levels low, we could see reductions in deaths and heart attacks that continue over time.
Future research will focus on identifying high-risk patients who might benefit from this approach, he said. An antiplatelet effect of CSL112 or a reduction of cholesterol in the arteries resulting from treatment with CSL112 could also explain the significant reduction in the number of heart attacks caused by a blood clot in a stent, he said. The reason strokes were not reduced may be that strokes can be caused by mechanisms other than the rupture of arterial blockages, he said.
A limitation of the study is that women, Black people and people of Asian heritage were underrepresented, which could reduce the findings generalizability, Gibson said.
The study was funded by CSL Behring, the manufacturer of CSL112
This study was simultaneously published online in the New England Journal of Medicine at the time of presentation. The findings of the exploratory analysis were/will be published in the Journal of the American College of Cardiology, JACC.
Gibson presented the study, Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results, on Saturday, April 6, the first day of the ACC Scientific Session being held thru April 8 in Atlanta, GA.
For more information: http://www.acc.org
Find more ACC24 conference coverage here
See the rest here:
- Applications of Nanotechnology in the Field of Cardiology - Cureus - April 15th, 2024 [April 15th, 2024]
- Tri-City Cardiology's Ambulatory Surgical Center (ASC) Leads the Way in Revolutionizing Heart Failure Management - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Watchdog group calls out risks associated with private equity in cardiology, other specialties - Cardiovascular Business - April 15th, 2024 [April 15th, 2024]
- Heart health: Cardiologist shares impact of advanced wearable technology on patient monitoring - News9 LIVE - April 15th, 2024 [April 15th, 2024]
- Apr 12 2024 This Week in Cardiology - Medscape - April 15th, 2024 [April 15th, 2024]
- TAVR Found Non-Inferior to SAVR for Low-Risk Patients - Diagnostic and Interventional Cardiology - April 15th, 2024 [April 15th, 2024]
- Telemedicine Strategy After MI Scores a Win in TELE-ACS - TCTMD - April 15th, 2024 [April 15th, 2024]
- Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030 - GlobeNewswire - April 15th, 2024 [April 15th, 2024]
- Impact of Interatrial Shunt May Vary by Heart Failure Type - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- SGLT-2 Inhibitors Show Mixed Results After Heart Attack - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Association of Black Cardiologists' "We Are The Faces" Campaign Unveils New Videos for Black Maternal Health Week - PR Newswire - April 7th, 2024 [April 7th, 2024]
- UNC Hospitals Performs First Transcatheter Tricuspid Valve Replacement in North Carolina | Newsroom - UNC Health and UNC School of Medicine - April 7th, 2024 [April 7th, 2024]
- Cardiawave is Presenting the 30-day Follow-up Results from its Valvosoft Pivotal Study on the Teatment of Severe ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24 - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Medicare drops AUC requirement for advanced imaging, ASNC celebrates - Cardiovascular Business - April 7th, 2024 [April 7th, 2024]
- Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions - Yale School of Medicine - April 7th, 2024 [April 7th, 2024]
- Getting Too Little Sleep Linked to High Blood Pressure - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- What's Going to Be Hot at ACC 2024 - TCTMD - April 7th, 2024 [April 7th, 2024]
- E-cigarette use linked to increased risk of heart failure, large study finds - News-Medical.Net - April 7th, 2024 [April 7th, 2024]
- Osso VR and ACC to Develop Cardiac Procedure Training with VR - HIT Consultant - April 7th, 2024 [April 7th, 2024]
- Kapil Yadav, M.D., Joins UAMS to Lead Nuclear Cardiology and Vascular Medicine Program - UAMS News - March 19th, 2024 [March 19th, 2024]
- Doctors form new coalition focused on reducing private equity's role in cardiology, other healthcare specialties - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Beth Israel Deaconess Medical Center cardiologist to be honored by American Heart Association - American Heart Association - March 19th, 2024 [March 19th, 2024]
- March 19 Doctors on Call Will Focus on Cardiology - KRSL - March 19th, 2024 [March 19th, 2024]
- Cardiologist shares his long journey from Libya to United States - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Cardiologists share historic research that led to FDA's long-awaited approval of coronary DCB - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Most physicians think private equity is bad for healthcare - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Meth-Related Cardiomyopathy: Where the Biggest Clusters Are - Medpage Today - March 19th, 2024 [March 19th, 2024]
- Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- Intravascular imaging during PCI in heart disease patients improves survival, reduces adverse outcomes - News-Medical.Net - March 19th, 2024 [March 19th, 2024]
- PA Martine Altieri Brings an Obesity Medicine Clinic to Her Cardiology Patients - AAPA - March 11th, 2024 [March 11th, 2024]
- WEGOVY APPROVED FOR HEART RISK: U-Mich cardiology, obesity medicine experts available for interview - Newswise - March 11th, 2024 [March 11th, 2024]
- AHA Sums Up AI's Potential in Cardiology, but Also the Hurdles Ahead - TCTMD - March 11th, 2024 [March 11th, 2024]
- Houston cardiology-focused tech platform exits to private equity, plans to scale - InnovationMap - March 11th, 2024 [March 11th, 2024]
- The Daylight Saving Time Health Effects You Might Not Be Expecting, According to a Cardiology Specialist (Exclusive) - PEOPLE - March 11th, 2024 [March 11th, 2024]
- How a big CMS update on carotid stenting could impact interventional cardiology - Cardiovascular Business - March 11th, 2024 [March 11th, 2024]
- Global Cardiology Medical Imaging Informatics Market - Cloud-powered Telecardiology to Improve Access to Healthcare - PR Newswire - March 11th, 2024 [March 11th, 2024]
- Valley Health cardiologist talks regional heart health | Nvdaily | nvdaily.com - Northern Virginia Daily - March 11th, 2024 [March 11th, 2024]
- With the correct research, AI in pediatric cardiology has great potential - Contemporary Pediatrics - March 11th, 2024 [March 11th, 2024]
- Top in cardiology: Cannabis use, heat exposure associated with higher stroke risk - Healio - March 11th, 2024 [March 11th, 2024]
- Researcher promotes subsidies to bring cardiac care closer to home in rural areas - Montana Right Now - March 11th, 2024 [March 11th, 2024]
- Cardiologist aims to improve care, reduce costly air transport - The Taos News - March 11th, 2024 [March 11th, 2024]
- Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk ... - Diagnostic and... - February 29th, 2024 [February 29th, 2024]
- Even Modest Lp(a) Elevations Bode Poorly for Cardiovascular Health - Medpage Today - February 29th, 2024 [February 29th, 2024]
- Bojangles surprises CMC cardiology team with heart-shaped biscuits for Heart Month - wpde.com - February 29th, 2024 [February 29th, 2024]
- Health Beat: Local cardiologists raise awareness about heart disease prevention - Iredell Free News - February 29th, 2024 [February 29th, 2024]
- Miami Valves 2024 Showcases Innovations in Structural Heart and Cardiovascular Care - InventUM - University of Miami - February 29th, 2024 [February 29th, 2024]
- Cardiology Specialists Keep a Pulse on Adults Born with Heart Defects - Checkup Newsroom - February 29th, 2024 [February 29th, 2024]
- A Living Legend of Health Equity in Stroke and Heart Disease - Penn Medicine - February 29th, 2024 [February 29th, 2024]
- Cardiologist at heart of TAVR controversy loses hospital privileges due to 'disruptive,' 'inexplicable' behavior - Cardiovascular Business - February 29th, 2024 [February 29th, 2024]
- Integration of pharmacist-led pharmacogenomics testing in cardiology clinical practice - Healio - February 29th, 2024 [February 29th, 2024]
- Foiled Theft of Medicines at Punjab Institute of Cardiology Highlights Organized Crime Concerns - BNN Breaking - February 29th, 2024 [February 29th, 2024]
- Feb 23 2024 This Week in Cardiology - Medscape - February 29th, 2024 [February 29th, 2024]
- Hospital doesnt miss a beat when it comes to cardiac care - Martha's Vineyard Times - February 29th, 2024 [February 29th, 2024]
- Cardiologist on the beat for healthy hearts | News, Sports, Jobs - Marietta Times - February 29th, 2024 [February 29th, 2024]
- One of few females in her field, Dr. Sheth focuses on educating women about heart health - Chicago Tribune - February 29th, 2024 [February 29th, 2024]
- URMC Hosts 'Heartbeat of Upson' Celebration | Lifestyle | upsonbeacon.com - upsonbeacon.com - February 29th, 2024 [February 29th, 2024]
- WVU, Valley Health offer pediatric cardiology in Tri-State | Special Sections | loganbanner.com - The Logan Banner - February 29th, 2024 [February 29th, 2024]
- First patient treated using A-Flux Reducer interventional system for angina - Cardiac Rhythm News - February 29th, 2024 [February 29th, 2024]
- Happy Holidays from the Diagnostic and Interventional Cardiology Team - Diagnostic and Interventional Cardiology - December 31st, 2023 [December 31st, 2023]
- 7 New Year's Resolutions for Heart Health From Cardiologists - Livestrong - December 31st, 2023 [December 31st, 2023]
- Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation ... - Diagnostic and Interventional... - December 31st, 2023 [December 31st, 2023]
- Smidt Heart Institute at Cedars-Sinai opens Aortic Surveillance Clinic for patients with enlarged aortas - News-Medical.Net - December 31st, 2023 [December 31st, 2023]
- Creatinine and Cystatin C-based GFR Estimation in HF Mortality - Physician's Weekly - December 31st, 2023 [December 31st, 2023]
- Holidays linked to surge in heart attacks, warns cardiology chief ahead of Christmas - WTOV Steubenville - December 22nd, 2023 [December 22nd, 2023]
- 5 trends in cardiology to watch - Harvard Health - December 22nd, 2023 [December 22nd, 2023]
- Top Policy and Practice News for Cardiologists in 2023 - TCTMD - December 22nd, 2023 [December 22nd, 2023]
- Colchicine Not the Answer for Recurring Arrhythmias After Ablation - Medpage Today - December 22nd, 2023 [December 22nd, 2023]
- Chamber Cardio Launches Innovative Value-Based Cardiology Care Platform with Early Success - PR Newswire - December 22nd, 2023 [December 22nd, 2023]
- Drinking in moderation can help avoid 'holiday heart syndrome' - UT Southwestern - December 22nd, 2023 [December 22nd, 2023]
- Top Cardiology Trials and Studies of 2023: Insights and Breakthroughs - Medriva - December 22nd, 2023 [December 22nd, 2023]
- Overview of Major Cardiology Trials in 2023 - Medriva - December 22nd, 2023 [December 22nd, 2023]
- New drugs, updated treatment strategies: 5 important trends in cardiology from an eventful 2023 - Cardiovascular Business - December 22nd, 2023 [December 22nd, 2023]
- The Top Cardiology Trials of 2023 - Medscape - December 22nd, 2023 [December 22nd, 2023]
- Cardiologists' Holiday Wish: Medicare Pay Cuts Roasting on an Open Fire - TCTMD - December 22nd, 2023 [December 22nd, 2023]
- Dec 15 2023 This Week in Cardiology - Medscape - December 22nd, 2023 [December 22nd, 2023]